AI assistant
Sending…
STRATA Skin Sciences, Inc. — Director's Dealing 2021
Mar 3, 2021
35146_dirs_2021-03-03_40d76c71-6f8c-4552-9c10-a6f615dc9573.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: STRATA Skin Sciences, Inc. (SSKN)
CIK: 0001051514
Period of Report: 2021-03-01
Reporting Person: Moccia Robert Joseph (Director, President & CEO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-03-01 | Employee Stock Option | $1.73 | A | 1632590 | Acquired | 2031-03-01 | Common Stock (1632590) | Direct |
Footnotes
F1: Stock options to purchase 544,198 shares of common stock vest on the first anniversary of the grant date, and stock options to purchase 136,049 shares of common stock vest on each of June 1, 2022, September 1, 2022, December 1, 2022, March 1, 2023, June 1, 2023, September 1, 2023, December 1, 2023 and March 1, 2024.
More from STRATA Skin Sciences, Inc.
Regulatory Filings
2026
Feb 11
Regulatory Filings
2025
Dec 17
Regulatory Filings
2025
Dec 10
Director's Dealing
2025
Nov 18
Interim / Quarterly Report
2025
Nov 14
Regulatory Filings
2025
Nov 13
Major Shareholding Notification
2025
Nov 7
Proxy Solicitation & Information Statement
2025
Oct 30
Regulatory Filings
2025
Oct 20
Regulatory Filings
2025
Oct 16